*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Cetus/NNP Corp./NNP ]
said/VBD 
[ the/DT French/JJ government/NN ]
gave/VBD 
[ it/PRP ]

[ approval/NN ]
to/TO market/VB 
[ its/PRP$ Proleukin/NNP interleukin-2/NN anti-cancer/JJ drug/NN ]
as/IN 
[ a/DT treatment/NN ]
for/IN 
[ kidney/NN cancer/NN ]
./. 

======================================

[ The/DT move/NN ]
is/VBZ 
[ a/DT shot/NN ]
in/IN 
[ the/DT arm/NN ]
for/IN 
[ the/DT biotechnology/NN concern/NN ]
,/, 
[ which/WDT ]
has/VBZ had/VBD 
[ heavy/JJ losses/NNS ]
while/IN developing/VBG 
[ the/DT drug/NN ]
and/CC 
[ other/JJ products/NNS ]
./. 

[ France/NNP ]
is/VBZ 
[ the/DT fourth/JJ ]
and/CC 
[ largest/JJS European/NNP Community/NNP country/NN ]
to/TO approve/VB 
[ the/DT marketing/NN ]
of/IN 
[ the/DT experimental/JJ drug/NN ]
,/, known/VBN as/IN 
[ IL-2/NNP ]
./. 

[ The/DT other/JJ countries/NNS ]
are/VBP 
[ Ireland/NNP ]
,/, 
[ the/DT Netherlands/NNP ]
and/CC 
[ Denmark/NNP ]
./. 

======================================

[ Cetus/NNP ]
said/VBD 
[ it/PRP ]
expects/VBZ to/TO begin/VB distributing/VBG 
[ the/DT drug/NN ]
in/IN 
[ France/NNP ]
within/IN 
[ the/DT next/JJ several/JJ weeks/NNS ]
,/, after/IN 
[ Cetus/NNP ]
and/CC 
[ a/DT committee/NN ]
of/IN 
[ several/JJ EC/NNP country/NN officials/NNS ]
negotiate/VBP 
[ a/DT price/NN ]
for/IN 
[ IL-2/NNP ]
./. 

[ Cetus/NNP ]
declined/VBD to/TO discuss/VB how/WRB 
[ much/JJ ]

[ it/PRP ]
hopes/VBZ to/TO charge/VB for/IN 
[ the/DT drug/NN ]
./. 

[ It/PRP ]
said/VBD 
[ an/DT estimated/VBN 9,400/CD people/NNS ]
are/VBP treated/VBN for/IN 
[ kidney/NN cancer/NN ]
in/IN 
[ France/NNP ]

[ each/DT year/NN ]
./. 

======================================

[ Cetus/NNP ]
expects/VBZ 
[ the/DT ]
remaining/VBG 
[ eight/CD EC/NNP countries/NNS ]
to/TO approve/VB marketing/NN of/IN 
[ IL-2/NNP ]
within/IN 
[ the/DT next/JJ six/CD months/NNS ]
./. 

[ The/DT company/NN ]
applied/VBD for/IN 
[ U.S./NNP Food/NNP ]
and/CC 
[ Drug/NNP Administration/NNP approval/NN ]
in/IN 
[ November/NNP ]
and/CC expects/VBZ to/TO receive/VB 
[ it/PRP ]
in/IN 
[ the/DT first/JJ ]

[ half/NN ]
of/IN 
[ 1990/CD ]
./. 
